UBS Group’s IDEAYA Biosciences IDYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25.4M Sell
762,548
-323,084
-30% -$10.8M ﹤0.01% 2337
2025
Q4
$37.5M Buy
1,085,632
+29,055
+3% +$926K 0.01% 1944
2025
Q3
$28.7M Buy
1,056,577
+304,672
+41% +$7.37M 0.01% 2176
2025
Q2
$15.8M Buy
751,905
+301,758
+67% +$5.79M ﹤0.01% 2624
2025
Q1
$7.37M Buy
450,147
+31,662
+8% +$675K ﹤0.01% 3376
2024
Q4
$10.8M Buy
418,485
+278,938
+200% +$7.9M ﹤0.01% 2957
2024
Q3
$4.42M Sell
139,547
-89,258
-39% -$3.38M ﹤0.01% 3203
2024
Q2
$8.03M Sell
228,805
-14,244
-6% -$564K ﹤0.01% 2416
2024
Q1
$10.7M Buy
243,049
+92,347
+61% +$3.97M ﹤0.01% 2217
2023
Q4
$5.36M Buy
150,702
+94,167
+167% +$2.81M ﹤0.01% 2713
2023
Q3
$1.53M Buy
56,535
+47,486
+525% +$1.2M ﹤0.01% 3706
2023
Q2
$213K Sell
9,049
-47,405
-84% -$975K ﹤0.01% 5436
2023
Q1
$775K Sell
56,454
-58,149
-51% -$969K ﹤0.01% 4331
2022
Q4
$2.08M Buy
114,603
+99,753
+672% +$1.68M ﹤0.01% 3356
2022
Q3
$222K Buy
14,850
+10,244
+222% +$133K ﹤0.01% 4999
2022
Q2
$64K Sell
4,606
-71,765
-94% -$798K ﹤0.01% 5740
2022
Q1
$854K Sell
76,371
-40,996
-35% -$604K ﹤0.01% 4266
2021
Q4
$2.77M Buy
117,367
+72,996
+165% +$1.7M ﹤0.01% 3441
2021
Q3
$1.13M Buy
44,371
+21,160
+91% +$494K ﹤0.01% 4088
2021
Q2
$487K Buy
23,211
+10,846
+88% +$223K ﹤0.01% 4758
2021
Q1
$291K Buy
12,365
+11,506
+1,339% +$222K ﹤0.01% 5225
2020
Q4
$12K Buy
859
+601
+233% +$8.14K ﹤0.01% 7343
2020
Q3
$3K Sell
258
-3,557
-93% -$44.1K ﹤0.01% 7533
2020
Q2
$54K Buy
3,815
+3,113
+443% +$24.5K ﹤0.01% 5787
2020
Q1
$3K Buy
+702
New +$4.97K ﹤0.01% 7490
2019
Q4
Sell
-3,023
Closed -$27K 8248
2019
Q3
$27K Buy
+3,023
New +$23.1K ﹤0.01% 6547

Other funds holding IDYA